about
B cells with regulatory properties in transplantation toleranceRegulatory cells and transplantation toleranceRegulatory B cells: an exciting target for future therapeutics in transplantationInterleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairB cells inhibit the antitumor immunity against an established murine fibrosarcomaThe excretory-secretory products of Echinococcus granulosus protoscoleces directly regulate the differentiation of B10, B17 and Th17 cells.Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cellsEnhanced frequency and potential mechanism of B regulatory cells in patients with lung cancerKiller B lymphocytes and their fas ligand positive exosomes as inducers of immune toleranceAntitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10Multiple mechanisms of immune suppression by B lymphocytesThe Expansion of CD25 high IL-10 high FoxP3 high B Regulatory Cells Is in Association with SLE Disease Activity.Role of B cells in host defense against primary Coxiella burnetii infection.Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression.Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cellsToll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.Coxiella burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells.Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes.Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA.Regulatory B cells in autoimmune diseases.Regulatory B cells in anti-tumor immunity.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.Induction and Differentiation of IL-10-Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients.B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice.B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatment.Upregulation of CD19⁺CD24(hi)CD38(hi) regulatory B cells is associated with a reduced risk of acute lung injury in elderly pneumonia patients.Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity.Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load.
P2860
Q26771404-85E5B653-AE84-41E5-892A-59705CFB532BQ26865816-3281BAFA-A58C-49B8-80D1-6D27C16C09AFQ27015093-1D0D8218-4158-4253-B356-23426A3E7AB8Q27310464-3CEC8684-CF1C-4DCF-BB48-2CDDA3D5A7CAQ28078211-A3C290B3-4ABF-4EA6-97D8-9E0679C131E8Q33684762-6A7B3C2B-946A-49EF-904B-868C49C4F1ADQ33921794-CAD859CA-E929-41A8-9C2C-29BF169D73EEQ34406496-B815945A-ADD8-4FF2-80E2-BAE9001DF04EQ34537331-7805B201-5065-402E-A56E-7092929D41C1Q35199945-306B37F3-1A3B-45EB-BCBA-F9E10E784270Q35554861-5C92A61D-D813-4FB1-BDB3-8F86670CA1E7Q35747533-0F53531F-632C-4E21-A6EA-AE51811ACB77Q36173186-A6E07DD1-445F-4954-9E7B-E157C60C6A81Q36281310-F1A18F64-80B0-43C3-8625-9D9BA40A5D0AQ36339395-4B52B450-C361-44D5-8AA7-6ED8D6774ABAQ36622214-1A7E83EB-1874-414B-A1C4-7B0BE4EC6E91Q36932371-0D5E931D-CB8E-4B51-8B1E-32E4A62870B4Q36979947-9F60C497-4481-4D91-BBA8-BE60C551D0E5Q37331969-E3F7731D-164A-47C6-AE40-D716D58E0ED0Q37350948-9C296DE5-E2BC-4C0E-83E4-8041C6A91C14Q37425047-CC95ED99-8C30-450A-8673-E1089DDDE132Q37692921-D125FA35-6792-4643-B917-6984832F2113Q37709222-79BB4FAE-13A5-40F6-8275-C2E854200E50Q37729359-F5680EFB-8F5F-4CE1-9F45-494B08713EAAQ38497066-FE87048C-F207-4C56-BD0F-F76E3B5DD0E2Q38848896-50C9BD43-2D50-4651-B829-D7FA34546752Q39021026-36378E07-0ABA-4C75-AB10-46C1D62A8051Q41551818-FBD696C1-4FC8-48B7-B408-F65EC260ADBEQ42097603-D77F4B9E-BB60-4BB1-82A6-223809988FACQ49011543-E5A98021-6F1F-40EC-8B8B-5F14DFF8294BQ51051361-40D67880-6528-4FB0-8A3D-585E7CA4ACFEQ52583000-0AA9E4A1-EE1B-465D-A231-2DE839CFA116
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Killer B lymphocytes: the evidence and the potential.
@ast
Killer B lymphocytes: the evidence and the potential.
@en
type
label
Killer B lymphocytes: the evidence and the potential.
@ast
Killer B lymphocytes: the evidence and the potential.
@en
prefLabel
Killer B lymphocytes: the evidence and the potential.
@ast
Killer B lymphocytes: the evidence and the potential.
@en
P2860
P1476
Killer B lymphocytes: the evidence and the potential.
@en
P2093
Steven K Lundy
P2860
P2888
P304
P356
10.1007/S00011-009-0014-X
P577
2009-03-05T00:00:00Z
P5875
P6179
1021192984